A detailed history of Cornerstone Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 247,400 shares of PFE stock, worth $6.52 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
247,400
Previous 247,400 -0.0%
Holding current value
$6.52 Million
Previous $6.92 Million 3.42%
% of portfolio
0.28%
Previous 0.28%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$25.26 - $29.6 $10,104 - $11,840
-400 Reduced 0.16%
247,400 $6.92 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $137,217 - $157,569
5,300 Added 2.19%
247,800 $6.88 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $517,374 - $672,012
-19,800 Reduced 7.55%
242,500 $6.98 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $628,964 - $735,196
19,600 Added 8.08%
262,300 $8.7 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $7.33 Million - $8.48 Million
202,900 Added 509.8%
242,700 $8.9 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $19.4 Million - $25.3 Million
-465,000 Reduced 92.12%
39,800 $2.04 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $4.14 Million - $5.06 Million
94,700 Added 23.09%
504,800 $22.1 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $19.1 Million - $22.6 Million
410,100 New
410,100 $21.5 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $7.2 Million - $9.15 Million
-215,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$31.75 - $37.25 $476,250 - $558,750
-15,000 Reduced 6.52%
215,000 $7.89 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $513,570 - $733,780
-19,000 Reduced 7.63%
230,000 $7.51 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $8.2 Million - $9.3 Million
249,000 New
249,000 $9.76 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cornerstone Advisors, LLC Portfolio

Follow Cornerstone Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.